Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis
BackgroundAlopecia areata (AA) is a chronic immune-mediated disorder causing non-scarring hair loss. Severe forms like alopecia totalis (AT) and alopecia universalis (AU) pose therapeutic difficult situations. Topical immunotherapy with squaric acid dibutylester (SADBE) and diphenylcyclopropenone (D...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-07-01
|
| シリーズ: | Frontiers in Medicine |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1573929/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
